Fleischmann R - Search Results

1

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE.

Fleischmann R, Blanco R, Van den Bosch F, Bessette L, Song Y, Penn SK, McDearmon-Blondell E, Khan N, Chan K, Mysler E. Fleischmann R, et al. Rheumatol Ther. 2024 Jun;11(3):599-615. doi: 10.1007/s40744-024-00658-1. Epub 2024 Mar 18. Rheumatol Ther. 2024. PMID: 38498140 Free PMC article.

2

Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.

Fleischmann RM. Fleischmann RM. J Rheumatol Suppl. 1992 Nov;36:32-40. J Rheumatol Suppl. 1992. PMID: 1474533 Clinical Trial.

3

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT. Fleischmann RM, et al. J Rheumatol. 2003 Apr;30(4):691-6. J Rheumatol. 2003. PMID: 12672185

4

Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.

Genovese MC, Bathon JM, Fleischmann RM, Moreland LW, Martin RW, Whitmore JB, Tsuji WH, Leff JA. Genovese MC, et al. J Rheumatol. 2005 Jul;32(7):1232-42. J Rheumatol. 2005. PMID: 15996057 Clinical Trial.

5

Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.

Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. Bathon JM, et al. Among authors: fleischmann rm. J Rheumatol. 2006 Feb;33(2):234-43. J Rheumatol. 2006. PMID: 16465653 Clinical Trial.

6

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.

Fleischmann R. Fleischmann R. Expert Opin Biol Ther. 2010 May;10(5):773-86. doi: 10.1517/14712591003724688. Expert Opin Biol Ther. 2010. PMID: 20230188 Review.

7

The efficacy and safety of golimumab in the treatment of arthritis.

Fleischmann R. Fleischmann R. Expert Opin Biol Ther. 2010 Jul;10(7):1131-43. doi: 10.1517/14712598.2010.493873. Expert Opin Biol Ther. 2010. PMID: 20504106 Review.

8

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM; IMAGE Investigators. Tak PP, et al. Ann Rheum Dis. 2011 Jan;70(1):39-46. doi: 10.1136/ard.2010.137703. Epub 2010 Oct 11. Ann Rheum Dis. 2011. PMID: 20937671 Clinical Trial.

9

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.

Kremer JM, Blanco R, Brzosko M, Burgos-Vargas R, Halland AM, Vernon E, Ambs P, Fleischmann R. Kremer JM, et al. Among authors: fleischmann r. Arthritis Rheum. 2011 Mar;63(3):609-21. doi: 10.1002/art.30158. Arthritis Rheum. 2011. PMID: 21360490 Free article. Clinical Trial.

10

Novel small-molecular therapeutics for rheumatoid arthritis.

Fleischmann R. Fleischmann R. Curr Opin Rheumatol. 2012 May;24(3):335-41. doi: 10.1097/BOR.0b013e32835190ef. Curr Opin Rheumatol. 2012. PMID: 22357358 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page